Combination treatment with anti‐Nogo‐A and chondroitinase ABC is more effective than single treatments at enhancing functional recovery after spinal cord injury
Rattachement africain : gb, ch. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
Anti-Nogo-A antibody and chondroitinase ABC (ChABC) enzyme are two promising treatments that promote functional recovery after spinal cord injury (SCI). Treatment with them has encouraged axon regeneration, sprouting and functional recovery in a variety of spinal cord and central nervous system injury models. The two compounds work, in part, through different mechanisms, so it is possible that their effects will be additive. In this study, we used a rat cervical partial SCI model to explore the effectiveness of a combination of anti-Nogo-A, ChABC, and rehabilitation. We found that spontaneous recovery of forelimb functions reflects the extent of the lesion on the ipsilateral side. We applied a combination treatment with acutely applied anti-Nogo-A antibody followed by delayed ChABC treatment starting at 3 weeks after injury, and rehabilitation starting at 4 weeks, to accommodate the requirement that anti-Nogo-A be applied acutely, and that rehabilitation be given after the cessation of anti-Nogo-A treatment. We found that single treatment with either anti-Nogo-A or ChABC, combined with rehabilitation, produced functional recovery of similar magnitude. The combination treatment, however, was more effective. Both single treatments produced increases in sprouting and axon regeneration, but the combination treatment produced greater increases. Anti-Nogo-A stimulated growth of a greater number of axons with a diameter of > 3 μm, whereas ChABC treatment stimulated increased growth of finer axons with varicosities. These results point to different functions of Nogo-A and chondroitin sulfate proteoglycans in axonal regeneration. The combination of anti-Nogo-A, ChABC and rehabilitation shows promise for enhancing functional recovery after SCI.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé, mais le titre doit être comparé manuellement.
- Titre Crossref
- Combination treatment with anti‐Nogo‐A and chondroitinase <scp>ABC</scp> is more effective than single treatments at enhancing functional recovery after spinal cord injury
- Date Crossref
- 24/06/2013
- Éditeur
- Wiley
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Cambridge Department of Clinical Neurosciences (Cambridge Centre for Brain Repair) pays non établi dans la noticeUniversité ou école supérieure
-
University of Zurich pays non établi dans la noticeUniversité ou école supérieure
-
ETH Zurich pays non établi dans la noticeUniversité ou école supérieure
-
Department of Health Sciences and Technologies Federal Institute of Technology (ETH) Zürich Switzerland pays non établi dans la noticeStructure de recherche
Department of Clinical Neurosciences (Cambridge Centre for Brain Repair) — University of Cambridge, University of Zurich et ETH Zurich, avec 1 autre affiliation.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.